Literature DB >> 2988307

Epstein-Barr virus infection and immunoregulation in man.

G Tosato, R M Blaese.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2988307     DOI: 10.1016/s0065-2776(08)60339-9

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


× No keyword cloud information.
  24 in total

1.  Detection and quantification of latently infected B lymphocytes in Epstein-Barr virus-seropositive, healthy individuals by polymerase chain reaction.

Authors:  H J Wagner; G Bein; A Bitsch; H Kirchner
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

Review 2.  Richter's transformation in chronic lymphocytic leukemia.

Authors:  Apostolia-Maria Tsimberidou; Michael J Keating; William G Wierda
Journal:  Curr Hematol Malig Rep       Date:  2007-10       Impact factor: 3.952

3.  Defective generation of killer cells against spontaneously Epstein-Barr virus (EBV)-transformed autologous B cells in a fatal EBV infection.

Authors:  M Yanagisawa; M Kato; K Ikeno; T Kobayashi; Y Miyagawa; A Komiyama; T Akabane
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

Review 4.  Epstein-Barr virus tissue tropism: a major determinant of immunopathogenesis.

Authors:  L Hutt-Fletcher
Journal:  Springer Semin Immunopathol       Date:  1991

5.  Epstein-Barr virus in human malignancy: a special reference to Epstein-Barr virus associated gastric carcinoma.

Authors:  Mee Soo Chang; Woo Ho Kim
Journal:  Cancer Res Treat       Date:  2005-10-31       Impact factor: 4.679

Review 6.  Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts.

Authors:  R J O'Reilly; T N Small; E Papadopoulos; K Lucas; J Lacerda; L Koulova
Journal:  Springer Semin Immunopathol       Date:  1998

7.  Epstein-Barr virus-immortalized B cells produce IL-6 as an autocrine growth factor.

Authors:  T Yokoi; T Miyawaki; A Yachie; K Kato; Y Kasahara; N Taniguchi
Journal:  Immunology       Date:  1990-05       Impact factor: 7.397

8.  Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity.

Authors:  D Wang; D Liebowitz; F Wang; C Gregory; A Rickinson; R Larson; T Springer; E Kieff
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

9.  Defective control of Epstein-Barr virus-infected B cell growth in patients with X-linked lymphoproliferative disease.

Authors:  N Yasuda; P K Lai; J Rogers; D T Purtlo
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

10.  Epstein-Barr virus latent membrane protein: induction of B-cell activation antigens and membrane patch formation does not require vimentin.

Authors:  D Liebowitz; E Kieff
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.